Pharmacology and Toxicology
Showing page 14 of 22 pages of list content
-
Small-MoleculeIn VitroInhibitors of the Coronavirus Spike – ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
This article's authors -
InVivoPharmacokinetic Study of Remdesivir Dry Powder for Inhalation in Hamsters
This article's authors -
Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mice Models
This article's authors -
A comparison of Remdesivir versus Au22Glutathione18in COVID-19 golden hamsters: a better therapeutic outcome of gold compound
This article's authors -
Losartan promotes cell survival following SARS-CoV-2 infectionin vitro
This article's authors -
Combinedin silicodocking and in vitro antiviral testing for drug repurposing identified lurasidone and elbasvir as SARS-CoV-2 and HCoV-OC43 inhibitors
This article's authors -
An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity
This article's authors -
Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screens
This article's authors -
SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray
This article's authors -
Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation
This article's authors